Operating CF
$22.87B
Capex
−$5.07B
Free Cash Flow
$17.80B
FCF Margin
+77.8%
Cash flow waterfall for Johnson & Johnson (JNJ) — TTM through Q1 2026
Free cash flow: $17.80B
Cash flow breakdown for Johnson & Johnson (JNJ) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Operating Cash Flow | $22.87B | $22.87B |
| Capital Expenditure | −$5.07B | $17.80B |
| Free Cash Flow | $17.80B | $17.80B |
| Acquisitions | −$17.54B | $257.00M |
| Other Investing | −$1.72B | −$1.46B |
| Share Buybacks | −$5.95B | −$7.41B |
| Dividends Paid | −$12.52B | −$19.94B |
| Other Financing & FX | $3.15B | −$16.79B |
| Net Cash Decrease | −$16.79B | −$16.79B |
- Operating Cash Flow$22.87B
- Capital Expenditure−$5.07B
- Free Cash Flow$17.80B
- Acquisitions−$17.54B
- Other Investing−$1.72B
- Share Buybacks−$5.95B
- Dividends Paid−$12.52B
- Other Financing & FX$3.15B
- Net Cash Decrease−$16.79B
Want to see what drove the FCF change?Free Cash Flow Bridge
Frequently asked questions
Data & methodology
Johnson & Johnson (JNJ) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement